Moderately hypofractionated post-operative radiation therapy for breast cancer: Systematic review and meta-analysis of randomized clinical trials
Gustavo Nader Marta, Rachel Riera, Rafael Leite Pacheco, Ana Luiza Cabrera Martimbianco, Icro Meattini, Orit Kaidar-Person, Philip Poortmans DOI: 10.1016/j.breast.2022.01.018 Full link: https://linkinghub.elsevier.com/retrieve/pii/S096097762200025X
International Association for the Study of Lung Cancer Study of the Impact of Coronavirus Disease 2019 on International Lung Cancer Clinical Trials
Matthew P Smeltzer, Giorgio V Scagliotti, Heather A Wakelee, Tetsuya Mitsudomi, Upal Basu Roy, Russell C Clark, Renee Arndt, Clayton D Pruett, Karen L Kelly, Peter Ujhazy, Melissa L Johnson , Yesim Eralp, Carlos H Barrios, Fabrice Barlesi, Fred R Hirsch, Paul A Bunn; DOI: 10.1016/j.jtho.2022.01.017 Full link: https://linkinghub.elsevier.com/retrieve/pii/S1556086422000867
The Lancet Summit: Cancer care in Asia and Latin America
July 14-15, 2022 | Online and On-Demand The Lancet Summit: Cancer care in Asia and Latin America will bring together key opinion leaders from across Asia and Latin America to highlight clinical and global oncology topics relevant for both regions in a post-pandemic world. The programme will encourage delegates to share experiences and learnings in both settings, foster interdisciplinary and multinational collaboration, and help inspire ideas to restore and improve cancer care and control. Topics include: Impact of COVID-19 on cancer care - future challenges and prioritiesHealth systems resiliencePalliative careCancer politics and policyNew technologies in cancer care Submissions are invited for contributed talks by February 18, 2022. To view the speakers and register visit: http://thelancetsummit.com/aosl
Innovation in Breast Cancer Symposium
The Innovation in Breast Cancer Symposium, will be held in online format on February 17th and 18th, 2022. The two-day international scientific program aims to provide state-of-the-art information on breast cancer, achieving a balance of clinical, translational, and basic research, as well as providing a forum for interaction, communication, and interdisciplinary education for specialists with a special interest in breast cancer. The registration period is now open. You can find all the information on the website through which you will have access to the registration section, general information, etc. Learn more: www.innovationinbreastcancer.com
SNOLA 2022 – Translational research to current and future treatments
It is with great satisfaction that we invite you all to participate in the conference SNOLA 2022 – Translational research to current and future treatments, which will take place on February 11th and 12th, 2022, 100% online. This will be the largest and most complete Neuro Oncology event in Latin America. Snola was born and remains focused on making accessible the content of knowledge and integration of all areas involved in oncological treatments of the of the Central Nervous System, therefore, we are committed to delivering the best of the best to Latin American specialists, as we always seek to do. Our last biannual congress had more than 1000 participants, 201 brazilian speakers, 76 international speakears and 7 sponsor. This success was achieved despite all the difficulties that this multidisciplinary area faces in scientific and practical terms. The world pandemic scenario made us change our plans, and the conference that would take place in 2020 in Buenos Aires had to be postponed. In view of the new reality, we proposed to hold the congress 100% online with scientific programming focused on what is new in our field, themes and studies that have shownpromise for new protocols, new approaches to the already known ones, as well
European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer
Icro Meattini, Carlotta Becherini, Liesbeth Boersma, Orit Kaidar-Person, Gustavo Nader Marta, Angel Montero, Birgitte Vrou Offersen, Marianne C Aznar, Claus Belka, Adrian Murray Brunt, Samantha Dicuonzo, Pierfrancesco Franco, Mechthild Krause, Mairead MacKenzie, Tanja Marinko, Livia Marrazzo, Ivica Ratosa, Astrid Scholten, Elżbieta Senkus, Hilary Stobart, Philip Poortmans, Charlotte E Coles DOI: https://doi.org/10.1016/S1470-2045(21)00539-8 Full link: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(21)00539-8/fulltext#articleInformation
Influence of physician’s lifestyle on the prescription of healthy habits to breast cancer patients (LACOG 1218)
Renata Cangussú, Eldsamira Mascarenhas, Taiane Francieli Rebelatto, Facundo Zaffaroni, Rafaela Gomes de Jesus, Paulo Ricardo Nunes Filho, Gustavo Werutsky DOI: https://doi.org/10.1007/s00520-022-06864-3 Full link: https://pubmed.ncbi.nlm.nih.gov/35102451/
European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer
Icro Meattini, Carlotta Becherini, Liesbeth Boersma, Orit Kaidar-Person, Gustavo Nader Marta, Angel Montero, Birgitte Vrou Offersen, Marianne C Aznar, Claus Belka, Adrian Murray Brunt, Samantha Dicuonzo, Pierfrancesco Franco, Mechthild Krause, Mairead MacKenzie, Tanja Marinko, Livia Marrazzo, Ivica Ratosa, Astrid Scholten, Elżbieta Senkus, Hilary Stobart, Philip Poortmans, Charlotte E Coles DOI: 10.1016/S1470-2045(21)00539-8 Full link: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(21)00539-8/fulltext